Editorial: Inflammasome, purinergic signaling, and immunometabolism in oral health and disease
Ana Carolina Morandini
Luiz Eduardo Baggio Savio- 1Department of Oral Biology and Diagnostic Sciences, Dental College of Georgia at Augusta University, Augusta, GA, United States
- 2Department of Periodontics, Dental College of Georgia at Augusta University, Augusta, GA, United States
- 3Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
Editorial on the Research Topic
Inflammasome, purinergic signaling, and immunometabolism in oral health and disease
Emerging evidence suggests a complex interplay between inflammasome activation, purinergic signaling, and immunometabolism, highlighting their interconnectedness in immune regulation. Purinergic signaling can regulate inflammasome activation by modulating Adenosine triphosphate (ATP) release or its metabolism. ATP released during inflammation can activate the NLRP3 inflammasome, promoting the maturation and secretion of pro-inflammatory cytokines (1). The NLRP3 inflammasome is a multi-protein complex, which is activated upon bacterial infections or cellular damage. Upon activation, pro-caspase1 is cleaved to active caspase1, which then proceeds to cleave the cytokine precursors pro-IL-1β and pro-IL-18 into their mature secreted forms (2). Additionally, inflammasome activation can influence purinergic signaling by affecting ATP release or enzymatic activities involved in ATP breakdown, altering the balance between pro-inflammatory ATP signaling and immunosuppressive adenosine signaling (3).
NLRP3 inflammasome is essential for defending against bacterial infections and misregulated NLRP3 inflammasome has been implicated in metabolic inflammatory disorders including type 2 diabetes, atherosclerosis, chronic kidney diseases (4), and respiratory disorders as reviewed by Leszczyńska et al. The authors elegantly discuss the contribution of NLRP3 inflammasome to the development of allergic rhinitis, allergic asthma, and chronic obstructive pulmonary disease. Huang et al. discussed the metals, which are widely used in dental implant manufacturing and dental crowns for oral rehabilitation in regards to their involvement in the activation of NLRP3 inflammasome. In this context, the cathepsins are a family of proteases that have been implicated in NLRP3 inflammasome activation following their activation with ATP, monosodium urate, silica crystals, or bacterial components, among others (5). In this regard, Jiang et al. explored the recent evidence in the pathogenic mechanisms between cathepsins and the most common oral diseases such as dental caries, periodontitis, oral cancer, and periapical lesions.
Metabolic reprogramming is a well-developed concept pertaining to changes in cellular bioenergetics (6) which has been embraced by the immunology field giving rise to immunometabolism (7) as one of the phenomena influencing intracellular pathways such as inflammasome activation and purinergic signaling. Metabolic intermediates can directly affect inflammasome assembly and cytokine production, while changes in energy metabolism can influence ATP release and cell death. In particular, ferroptosis, a type of iron-dependent autophagy-related cell death (8, 9) has been described by Xie et al. underlying the pathological and functional mechanisms underlying ferroptosis in irreversible pulpitis. Furthermore, Liu et al. explored a recently discovered cell death pathway initiated by copper ion clusters named cuproptosis using a wide array of cutting-edge bioinformatics approaches to evaluate existing human gingival tissue gene expression datasets, thus providing an innovative possible connection between cuproptosis and periodontitis. Finally, Hou et al. provide a comprehensive review on the relationship between high levels of uric acid and periodontitis. The authors discuss the pathogenic mechanisms driving periodontitis and the systemic impact of hyperuricemia, and summarize the link between the two disease mechanisms, wrapping up this special research topic.
In summary, this Special Issue offers a great overview of how inflammasome, purinergic signaling, and immunometabolism affect oral health and disease. The points discussed in this issue open new avenues for future research on these signaling pathways to better understand the physiological and pathological mechanisms underlying oral disease.
Author contributions
ACM wrote the first draft. LEBG edited the text. All authors contributed to the article and approved the submitted version.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1. Di Virgilio F. Liaisons dangereuses: P2X(7) and the inflammasome. Trends Pharmacol Sci. (2007) 28(9):465–72. doi: 10.1016/j.tips.2007.07.002
2. Martin-Sanchez F, Diamond C, Zeitler M, Gomez AI, Baroja-Mazo A, Bagnall J, et al. Inflammasome-dependent IL-1beta release depends upon membrane permeabilisation. Cell Death Differ. (2016) 23(7):1219–31. doi: 10.1038/cdd.2015.176
3. Morandini AC, Savio LE, Coutinho-Silva R. The role of P2X7 receptor in infectious inflammatory diseases and the influence of ectonucleotidases. Biomed J. (2014) 37(4):169–77. doi: 10.4103/2319-4170.127803
4. Yu JW, Lee MS. Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance. Arch Pharm Res. (2016) 39(11):1503–18. doi: 10.1007/s12272-016-0827-4
5. Campden RI, Zhang Y. The role of lysosomal cysteine cathepsins in NLRP3 inflammasome activation. Arch Biochem Biophys. (2019) 670:32–42. doi: 10.1016/j.abb.2019.02.015
6. Yoshida GJ. Metabolic reprogramming: the emerging concept and associated therapeutic strategies. J Exp Clin Cancer Res. (2015) 34:111. doi: 10.1186/s13046-015-0221-y
7. O'Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. (2016) 16(9):553–65. doi: 10.1038/nri.2016.70
8. Zhou B, Liu J, Kang R, Klionsky DJ, Kroemer G, Tang D. Ferroptosis is a type of autophagy-dependent cell death. Semin Cancer Biol. (2020) 66:89–100. doi: 10.1016/j.semcancer.2019.03.002
Keywords: inflammasome, purinergic signaling, immunometabolism, periodontitis, oral health, NLRP3 inflammasome, adenosine triphosphate
Citation: Morandini AC and Savio LEB (2023) Editorial: Inflammasome, purinergic signaling, and immunometabolism in oral health and disease. Front. Oral. Health 4:1236507. doi: 10.3389/froh.2023.1236507
Received: 7 June 2023; Accepted: 8 June 2023;
Published: 16 June 2023.
Edited and Reviewed by: Georgios N. Belibasakis, Karolinska Institutet (KI), Sweden
© 2023 Morandini and Savio. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ana Carolina Morandini amorandini@augusta.edu